Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 42 citing articles:

Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems
Paola Maria Cutroneo, Daniele Sartori, Marco Tuccori, et al.
Frontiers in Drug Safety and Regulation (2024) Vol. 3
Open Access | Times Cited: 42
Depression and Anxiety Disorders
Oğuz Karamustafalıoğlu, Hüseyin Yumrukçal
(2025), pp. 335-476
Closed Access | Times Cited: 7
A multidimensional assessment of adverse events associated with paliperidone palmitate: a real-world pharmacovigilance study using the FAERS and JADER databases
Siyu Lou, Zhiwei Cui, Yingyong Ou, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Vortioxetine-associated syndrome of inappropriate ADH secretion
Sreedevi Sugunan, K.P. Lakshmi, Bindu Menon
BMJ Case Reports (2025) Vol. 18, Iss. 2, pp. e262735-e262735
Closed Access | Times Cited: 1
The impact of anti-TNFα agents on weight-related changes: new insights from a real-world pharmacovigilance study using the FDA adverse event reporting system (FAERS) database
Faizan Mazhar, Vera Battini, Michele Gringeri, et al.
Expert Opinion on Biological Therapy (2021) Vol. 21, Iss. 9, pp. 1281-1290
Closed Access | Times Cited: 41
Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System
Michele Fusaroli, Emanuel Raschi, Valentina Giunchi, et al.
The International Journal of Neuropsychopharmacology (2022) Vol. 25, Iss. 9, pp. 727-736
Open Access | Times Cited: 27
The potential antidepressant effect of antidiabetic agents: New insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBase
Vera Battini, Robbert P. van Manen, Michele Gringeri, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
The risk of antidepressant-induced hyponatremia: A meta-analysis of antidepressant classes and compounds
Tim Gheysens, Filip Van Den Eede, Livia De Picker
European Psychiatry (2024) Vol. 67, Iss. 1
Open Access | Times Cited: 5
Randomized, double‐blind, placebo‐controlled 8‐week trial of the efficacy, safety, and tolerability of 5, 10, and 20 mg/day vortioxetine in adults with major depressive disorder
Akira Nishimura, Yutaka Aritomi, Kiyofumi Sasai, et al.
Psychiatry and Clinical Neurosciences (2017) Vol. 72, Iss. 2, pp. 64-72
Open Access | Times Cited: 40
Updated Insights on Levetiracetam-Associated Severe Cutaneous Adverse Reactions: A Real-World Pharmacovigilance Analysis
Zhanshen Wu, Yang Zhao, Xiangyu Zhang, et al.
Expert Opinion on Drug Safety (2025)
Closed Access
An Instant Relationship Between Hyponatremia, Geriatric Syndromes, and Drugs in Older Adults: A Cross-Sectional Analysis from a Single Geriatric Clinic
Ali Ekrem Aydın, Esra Ateş Bulut, Süleyman Emre Koçyiğit, et al.
Diagnostics (2025) Vol. 15, Iss. 6, pp. 744-744
Open Access
Exploring the underlying mechanisms of drug‐induced impulse control disorders: a pharmacovigilance‐pharmacodynamic study
Michele Fusaroli, Valentina Giunchi, Vera Battini, et al.
Psychiatry and Clinical Neurosciences (2022) Vol. 77, Iss. 3, pp. 160-167
Open Access | Times Cited: 16
Vortioxetine‐induced syndrome of inappropriate secretion of antidiuretic hormone: A case report
Taro Sasaki, Yunosuke Shindo, Kota Kikuchi, et al.
Neuropsychopharmacology Reports (2024) Vol. 44, Iss. 2, pp. 479-481
Open Access | Times Cited: 3
Inflammasome Targeted Therapy in Pregnancy: New Insights From an Analysis of Real-World Data From the FAERS Database and a Systematic Review
Carla Carnovale, Enrico Tombetti, Vera Battini, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 19
Psychotropic drug-induced hyponatremia: results from a drug surveillance program–an update
Johanna Seifert, Martin Letmaier, Timo Greiner, et al.
Journal of Neural Transmission (2021) Vol. 128, Iss. 8, pp. 1249-1264
Open Access | Times Cited: 18
The Role of Vortioxetine in the Treatment of Depressive Symptoms in General Hospital Psychiatry: A Case-Series and PRISMA-Compliant Systematic Review of the Literature
Francesco Weiss, Bruno Pacciardi, Giulia D’Alessandro, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 531-531
Open Access | Times Cited: 2
The atypical antipsychotics and sexual dysfunction: a pharmacovigilance-pharmacodynamic study
Cheng Yu, Youjun Chen, Xue Zhao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Identifying Antidepressants Less Likely to Cause Hyponatremia: Triangulation of Retrospective Cohort, Disproportionality, and Pharmacodynamic Studies
Takuya Nagashima, T. Hayakawa, Hayato Akimoto, et al.
Clinical Pharmacology & Therapeutics (2022) Vol. 111, Iss. 6, pp. 1258-1267
Open Access | Times Cited: 10
Vortioxetine – pharmacological properties and use in mood disorders. The current state of knowledge
Anna Julia Krupa, Krzysztof Wojtasik-Bakalarz, Marcin Siwek
Psychiatria Polska (2022) Vol. 57, Iss. 6, pp. 1109-1126
Open Access | Times Cited: 10
Beta‐blocker‐associated hypoglycaemia: New insights from a real‐world pharmacovigilance study
Carla Carnovale, Michele Gringeri, Vera Battini, et al.
British Journal of Clinical Pharmacology (2021) Vol. 87, Iss. 8, pp. 3320-3331
Open Access | Times Cited: 14
Hyponatremia Associated with the Use of Common Antidepressants in the All of Us Research Program
Huan Mo, Yamna Channa, Tracey M. Ferrara, et al.
Clinical Pharmacology & Therapeutics (2024)
Closed Access | Times Cited: 1
Safety of fexofenadine and other second-generation oral antihistamines before and after the removal of the prescription requirement in Italy and other European countries: A real-world evidence study and systematic review
Carla Carnovale, Vera Battini, Michele Gringeri, et al.
World Allergy Organization Journal (2022) Vol. 15, Iss. 7, pp. 100658-100658
Open Access | Times Cited: 7
Hyponatremia Following Antipsychotic Treatment: In Silico Pharmacodynamics Analysis of Spontaneous Reports From the US Food and Drug Administration Adverse Event Reporting System Database and an Updated Systematic Review
Faizan Mazhar, Vera Battini, Marco Pozzi, et al.
The International Journal of Neuropsychopharmacology (2021) Vol. 24, Iss. 6, pp. 477-489
Open Access | Times Cited: 9
Antibiotic-Induced Neutropenia in Pediatric Patients: New Insights From Pharmacoepidemiological Analyses and a Systematic Review
Vera Battini, Alessandra Mari, Michele Gringeri, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
On the potential of drug repurposing in dysphagia treatment: New insights from a real-world pharmacovigilance study and a systematic review
Vera Battini, Sara Rocca, Greta Guarnieri, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top